CN|EN
CN

News

Company News >
your current location: News>Company News

H008 approved IND by FDA

2020.06.28  Share to:  

On 28th.June.2020, H008 has approved IND by FDA. Clinical study may proceed in USA

Employee login|

Enterprise OA Line 1 Line 2

Business office

Customer notice|
Notice for returns after sale Instructions for handling the first camp
Sitemap| Legal Notices| Contact us

© Copyright 2021 Jiangsu Carephar Pharmaceutical Co., Ltd. All Rights Reserved.

公安 Su Gong Wang An Bei No. 32010202010386


Su ICP Bei No. 12053319-3  | (Su)–Non-business–2021-0036 (Internet Drug Information Service Qualification Certificate)